Nervous system Flashcards
Which classes of drugs have anitmuscarinic (anticholinergic) burden?
Antimuscarinic drugs result in cognitive impairment (use minimised in dementia)
- antidepressants (e.g. amitriptyline & paroxetine)
- antihistamines (e.g. chlorphenamine & promethazine)
- antipsychotics (e.g. olazapine & quetiapine)
- urinary spasmodics (solifenacin & tolterodine)
How do you treat cognitive symptoms in mild-moderate Alzheimer’s disease?
1st line: Acetylcholinesterase inhibitors - monotherapy with donepezil, galantamine, or rivastigmine
2nd line: memantine (in moderate AD)
How do you treat cognitive symptoms in severe Alzheimer’s disease?
1st line: memantine
If pt already receiving Acetylcholinesterse inhibitor already, the addition of memantine can be started in primary care
How do you treat cognitive symptoms in mild-to-moderate non-alzheimer’s dementia?
Donepezil or rivastigmine in mild-moderate non-alzheimer’s dementia with Lewy bodies
- if both not tolerated then galantamine can be considered
How do you treat cognitive symptoms in severe non-alzheimer’s dementia?
Donepezil or rivastigmine in severe non-alzheimer’s dementia with Lewy bodies
- C/I or not tolerated = memantine
When can memantine be considered to treat cognitive symptoms in non-alzheimer’s dementia?
In patients with vascular dementia if they have suspected co-morbid AD, parkinsons disease dementia or dementia with Lewy bodies
Who are acetylcholinesterase inhibitors and memantine contraindicated in?
Patient with frontotemportal dementia or cognitive impairment caused by multiple sclerosis
What should you consider before treating agitation, aggression, distress and psychosis in patient with dementia?
Antipsychotics should ONLY be considered if:
- Pt is at risk of harming themselves or others
- experiencing agitation, hallucinations or delusions that are causing severe distress
What is the MHRA warning for antipsychotics and dementia?
Increases risk of stroke and small increases risk of death when antipsychotics are used in elderly patient WITH dementia
Assess risks v benefits
- including previous history of stroke or TIA
- risk factors for cerebrovascular disease: e.g. hypertension, diabetes, smoking and AF
If antipsychotic medication is decided to commence in patients with dementia, when should they be reviewed?
Every 6 weeks
Treat with the lowest dose for the shortest period of time
What types of dementia do antipsychotics worsen?
Patient with dementia with lewy bodies or parkinsons disease dementia - antipsychotic drugs worsen motor features of condition and in some cases cause antipsychotic sensitivity reactions
How is depression and anxiety treated in dementia?
Psychological treatments for mild-moderate dementia - CBT, multi-sensory stimulation, relaxation or animal-assisted therapies
Antidepressants should be reserved for pre-existing severe mental health problems
What is the STOPP criteria for donepezil, galantamine and rivastigmine?
- known history of persistent bradycardia
- HR less than 60 beats per minute
- heart block
- recurrent unexplained syncope
- concurrent treatments with drugs that reduce HR
What is the patient and carer advise for galantamine?
Warn of the signs of serious skin reactions - advised to stop taking immediately and seek medical advise (steven-johnsons syndrome)
When should rivastigmine treatment be interrupted?
If dehydration resulting in prolonged vomiting or diarrhoea occurs and withheld until resolution - retitrate dose if necessary
What is the conversion between oral rivastigmine and transdermal patch?
Taking between 3-9mg orally = start with 4.6mg/24 hr patch
Taking 9mg orally = switch to 9.5mg/24hr patch
Taking 12mg orally = switch to 9.5mg/24 hr patch
Patch can be started the day following last oral dose
Transdermal patches less likely to cause side effects
Where do you apply the rivastigmine patch?
clean, dry, non-hairy, non-irritated skin on:
- back
- arm
- check
Removing after 24 hours
Avoid using the same area for 14 days
Which anti-epileptics have a long half-life and can be taken OD at night?
Lamotrigine
Perampanel
Phenobarbital
Phenytoin
What are the MHRA warnings for anti-epileptic drugs?
- risk of suicidal thoughts and behaviours (symptoms may occur as early as 1 week after starting treatment)
- advice on switching between different manufacturer’s products
- teratogenicity: valportate must not be used in females of child-bearing age unless conditions of the PPP are met and alternative treatments contraindicated or not appropriate
What anti-epileptic drugs are category 1 and should be prescribed and maintained on a specific brand?
Carbamazepine
Phenobarbital
Phenytoin
Primidone
What anti-epileptic drugs are category 2 and prescribing by brand is based on clinical judgment and the patient?
Clobazam
Clonazepam
Lamotrigine
Topiramate
Valporate
Which drugs is anti-epileptic hypersensitivity syndrome associated with?
Carbamazepine
Lacosamide
Lamotrigine
Oxcarbazepine
Phenobarbital
Primidone
Rufinamide
Symptoms start between 1-8 weeks of exposure
Withdraw drug immediately - do not re-expose
What are the symptoms of hypersensitivity syndrome?
common: fever, rash and lymphadenopathy
other systemic signs: liver dysfunction, haematological, renal and pulmonary abnormalities, vasculitis and multi-organ failure
Which anti-epileptics can precipitate severe rebound seizures if stopped abruptly?
Barbiturates
Benzodiiazepines